MedTrace Logo

Setria Performance Blend Supplementation

NCT04090138 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2021-04-20

No results posted yet for this study

Summary

The objective of this trial is to evaluate the effects of setria performance blend supplementation on endurance performance in healthy men.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Setria performance blend

Oral capsules

DIETARY_SUPPLEMENT

Placebo

Oral capsules

Sponsors & Collaborators

  • Kirin Holdings Company, Limited

    collaborator INDUSTRY

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Abbie Smith-Ryan, PhD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-30
Primary Completion
2020-11-01
Completion
2020-11-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04090138 on ClinicalTrials.gov